Tamoxifen

Basic tamoxifen information

• INN (international nonproprietary name): Tamoxifen
• Brand names available in the United Kingdom: Nolvadex, Soltamox (oral solution); generic tamoxifen
• ATC code: L02BA01
• Forms and dosages: Oral tablets 10 mg and 20 mg; oral solution 10 mg/5 mL
• Manufacturers in the United Kingdom: Teva, Sandoz, Accord Healthcare and other generic suppliers
• Registration status in the United Kingdom: Prescription-only medicine (POM)
• OTC / Rx classification: Prescription-only medicine (POM)

Tamoxifen at a glance

Looking at tamoxifen for the first time, many patients want the same straightforward answer: what is it, who uses it, and why does the pharmacy ask for a prescription?

In UK practice, tamoxifen is a prescription-only medicine and an MHRA-approved oral anti-oestrogen used mainly in breast cancer care.

It is part of the SERM class, which means selective oestrogen receptor modulator, and it is commonly supplied as tamoxifen 20mg tablets or, less often, as an oral solution.

Brand names include Nolvadex and Soltamox; the generic name is tamoxifen citrate.

Not every request is suitable for supply, though, because this medicine is not for OTC sale and needs a proper clinical review first.

What it is

A prescription-only oral antiestrogen used in hormone-responsive conditions.

Available forms

Usually 10 mg or 20 mg tablets, or Soltamox oral solution 10 mg/5 mL.

What it is used for

Breast cancer treatment, recurrence prevention, risk reduction, and selected specialist-led off-label use.

Who it is for: adults prescribed tamoxifen citrate for breast cancer, risk reduction, or specialist-guided hormonal management.

Who it is not for: people who are pregnant, breastfeeding, or have a history of DVT or PE, unless a specialist says otherwise.

Prescription-only status and why it matters

Because tamoxifen is Rx-only, the pharmacy has to check the prescription, the dose, and the clinical reason before supply.

That matters for safety because of the clotting and eye-related risks.

Real-world use cases: breast cancer treatment, risk reduction, fertility, gynaecomastia

Most prescriptions relate to early breast cancer, ductal carcinoma in situ, metastatic disease, or risk reduction in higher-risk patients.

Specialists also sometimes use it off-label for gynaecomastia or fertility regimens, where tamoxifen can be part of a hormone therapy plan.

Legal status in the UK

Tamoxifen is a prescription-only medicine (POM) in the UK.

In our online pharmacy, tamoxifen is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Brand names, generics and packaging

Patients often think they are changing medicines when they see a different box, but the active ingredient may still be tamoxifen.

In the UK, the names most commonly seen are Nolvadex and Soltamox (oral solution), alongside generic tamoxifen tablets.

Tablets are supplied as blister strips of 10 mg and 20 mg, and the oral solution (10 mg/5 mL) is supplied in bottles for those who cannot swallow tablets.

Generic versus branded: generic tamoxifen and branded Nolvadex tablets contain the same active medicine, but the pack appearance and supplier can differ.

That is why patients should always check the strength, the name on the label, and the directions on the dispensing bag.

Pack sizes, tablet blisters and liquid option

Most people receive tablets in standard blister packaging, while the liquid form is usually reserved for specific situations.

Generic tamoxifen versus branded Nolvadex

When patients compare generic tamoxifen with branded Nolvadex tablets, the main differences are usually the manufacturer and the outer packaging.

What tamoxifen is and how it works in plain English

People are often told tamoxifen blocks oestrogen, but that phrase needs a bit of explanation to be useful.

It is a selective oestrogen receptor modulator, or SERM, which means it behaves differently in different tissues.

In some tissues it acts as a competitive oestrogen blocker, while in others it has more mixed activity.

The medicine is listed in the ATC system as L02BA01, which places it in endocrine therapy under anti-oestrogens.

After the body processes it, part of its effectiveness depends on conversion through CYP2D6 to endoxifen.

SERM

A medicine that acts on oestrogen receptors in a tissue-specific way.

Oral antiestrogen

A tablet or liquid medicine taken by mouth to block oestrogen signalling in selected cancers.

Endoxifen

An active metabolite linked to tamoxifen efficacy.

Simple pathway: tamoxifen tablets are taken by mouth, the liver helps convert part of the dose, and endoxifen contributes to the anti-oestrogen effect.

Why this matters: medicines that affect CYP2D6 can change the amount of active metabolite the patient gets.

Definition: selective oestrogen receptor modulator

This drug class is why tamoxifen can be useful in breast tissue without behaving the same way everywhere in the body.

Why it blocks oestrogen in some tissues but not all

The receptor effect varies by tissue, so the clinical result depends on where the oestrogen signal needs to be blocked.

Why metabolism to endoxifen matters

Some patients may need endoxifen level testing if there are concerns about metabolism, interactions, or response.

Who tamoxifen is prescribed for in UK practice

Patients usually want to know whether the prescription they have been given matches the condition they have been told about.

In UK practice, tamoxifen is used for early breast cancer after surgery, ductal carcinoma in situ, metastatic disease, and risk reduction in selected high-risk patients.

It may also be used off-label in specialist settings for gynaecomastia or fertility regimens.

For many patients, hormone therapy is not a short course but part of a long treatment plan.

That is why oncology specialist input matters before changing anything.

Early breast cancer after surgery

This is one of the most common uses, and the standard dose is usually 20 mg once daily.

Ductal carcinoma in situ and recurrence prevention

After surgery for DCIS, tamoxifen may be prescribed for five years to lower the chance of recurrence.

Metastatic breast cancer and extended treatment

When breast cancer is metastatic, the dose may be 20 to 40 mg a day and treatment continues while there is benefit.

Off-label use: gynaecomastia and fertility specialist regimens

These uses are specialist guided.

Dosage forms and strengths

Formulation choice is often practical rather than dramatic: can the patient swallow tablets, and what strength has been prescribed?

Most prescriptions are for tablets, usually 10 mg or 20 mg, but an oral solution is available as 10 mg/5 mL.

Compounded suspension may be used by a hospital pharmacy when a child or a very specific formulation is needed.

For most adults, tamoxifen 20mg tablets are the default choice.

Liquid tamoxifen is practical when a tablet blister is not suitable, but it still needs careful checking before use.

Tablets, oral solution, and compounded suspension

Tablets are the usual form, oral solution is less common, and compounded forms are rare.

Choosing 10 mg versus 20 mg packs

Strength selection depends on the prescribed daily dose and the pack size needed for the treatment plan.

When a liquid form is practical

Oral solution can help when swallowing is a problem, but the dose must be measured accurately every time.

How to take tamoxifen safely and consistently

Many patients worry about getting the routine right, especially when the medicine is taken for years rather than weeks.

Once-daily dosing helps, but only if the patient can build it into a stable habit.

A simple morning routine, a phone reminder, or keeping the pack beside other regular medicines can make a real difference.

• Take it at the same time each day.
• Swallow tablets with water.
• Keep the dose consistent rather than changing it on your own.
• Record any missed dose in a note or medication app.

Do: take a missed dose as soon as remembered if it is still appropriate to do so.

Don’t: double up to make up for a forgotten dose.

If someone has taken too much, symptoms may include tremor, unsteady gait, and dizziness, and medical advice should be sought promptly.

Once-Daily routine and adherence tips

Adherence is easier when the dose is linked to a regular daily activity.

Food, swallowing, and timing habits

Patients usually focus on being consistent rather than worrying about elaborate timing rules.

What to do with missed doses

The key message is simple: take it when remembered, unless it is nearly time for the next dose, and never double up.

Overdose signs and advice

Overdose advice is symptom-based because there is no specific antidote.

Duration of treatment: why tamoxifen is often a long-term medicine

This medicine is often taken for years, which can surprise patients who expected a short course.

Chronic administration is usually required for hormone-responsive cancers, and adjuvant treatment commonly lasts five to ten years.

That long horizon is why treatment plans are often reviewed over time rather than finished after one appointment.

Some people stay on therapy longer if the oncologist believes the clinical benefit remains strong.

Five-year and ten-year treatment plans

Five years is common, while ten years may be used in selected adjuvant regimens.

When therapy may be extended or stopped

Side effects, resistance, or specialist reassessment can lead to continuation, interruption, or a switch.

Why specialist review matters before discontinuation

Stopping without oncology advice can undermine the treatment plan and should be avoided.

Contraindications and when tamoxifen should not be used

Before supply, pharmacists need to check for a few clear red flags.

The main ones are pregnancy, breastfeeding, past or active DVT or PE, hypersensitivity, and concurrent coumarin-type anticoagulant use.

These are not minor warnings, because the risk profile changes substantially in those settings.

Absolute contraindications

Pregnancy, lactation, hypersensitivity, active or past deep vein thrombosis or pulmonary embolism, and coumarin-type anticoagulant use.

Relative cautions

Severe hepatic impairment, pre-existing uterine disease or endometrial cancer, hyperlipidaemia, bone metastases at initiation, and blood cell disorders.

Warning: tamoxifen should be used carefully in liver impairment, and severe liver impairment is not recommended.

Because clot risk is a known issue, any new calf swelling, chest pain, or sudden breathlessness needs urgent assessment.

Absolute contraindications

These include pregnancy, lactation, hypersensitivity, active or past DVT or PE, and coumarin-type anticoagulants.

Relative contraindications and higher-risk situations

Uterine disease, severe hepatic impairment, and bone metastases can all make the treatment decision more cautious.

Pregnancy, breastfeeding, and anticoagulant interactions

These situations need specific prescriber review rather than routine supply.

Side effects patients notice most often — and what is more serious

Most patients want to know what is likely to happen day to day, and what should trigger a call to the clinic.

Common effects are often manageable, but a few problems need prompt attention.

Hot flushes are one of the most common reasons patients say the medicine is hard to tolerate.

Vaginal bleeding should always be reported, particularly if it is new or persistent.

Long-term therapy also means the uterus, clotting system, and eyes need proper attention during follow-up.

Common mild-to-moderate effects

These include flushing, fatigue, nausea, vomiting, vaginal discharge or bleeding, menstrual changes, cramps, headache, rash, and thinning hair.

Red flags requiring prompt clinical review

Blood clot symptoms, vision changes, and persistent abnormal bleeding should never be ignored.

Uterine, clotting, and vision-related concerns

These risks are part of why review appointments matter during long-term treatment.

Interactions, metabolism, and endoxifen testing

This is one of the most important sections for safe prescribing, because tamoxifen efficacy is partly linked to CYP2D6 metabolism.

Some antidepressants can reduce the amount of active metabolite formed, which may reduce efficacy.

In particular, paroxetine and fluoxetine are medicines that should be avoided or carefully reviewed with the prescriber.

The interaction issue is one reason pharmacists ask about all regular medicines, including over-the-counter products and mental health treatments.

Blood monitoring for endoxifen is not routine for everyone, but it may be recommended in selected populations.

That is particularly relevant when response, side effects, or drug interactions are causing concern.

CYP2D6 and why some antidepressants matter

CYP2D6 helps convert tamoxifen to endoxifen, so inhibition can matter clinically.

SSRIs to avoid or review with a prescriber

Paroxetine and fluoxetine are the clearest examples.

When blood monitoring may be considered

Endoxifen level testing may be useful in selected patients where metabolism is in doubt.

Special populations: age, renal function, liver disease, and paediatrics

Most adults do not need a routine dose change simply because they are older.

The elderly usually need no adjustment, although side effects still need monitoring because metabolism may slow with age.

Renal impairment does not require a specific dose adjustment, but caution is still sensible in practice.

The liver is more important here, because tamoxifen is hepatically metabolised and severe hepatic impairment is not recommended.

Paediatric use is rare, unlicensed, and specialist led, which means routine community supply is unusual.

In short, age alone rarely changes the dose, but liver disease can.

Elderly patients and routine adjustment

No routine adjustment is needed, but regular review is still sensible.

Renal impairment versus hepatic impairment

Kidney function is less of a dosing issue than severe liver impairment.

Paediatric use and unlicensed scenarios

Children should only receive it under specialist guidance, usually in hospital-led care.

Storage and handling at home

Storage is straightforward, but it matters because the medicine is often kept at home for a long time.

Store it at 15 to 30 degrees Celsius, in the original packaging, away from moisture and direct sunlight.

Oral solutions must not be frozen, and expiry dates should be checked before travel or repeat dispensing.

• Keep tablets in the original blister or carton.
• Do not store the medicine in a damp bathroom cupboard.
• Protect bottles and blisters from heat and sunlight.
• Check the expiry date before taking it on holiday.

Room temperature storage and moisture protection

Original packaging gives the best protection in day-to-day home use.

Transport advice for travel and repeat prescriptions

Travelling patients should carry enough supply, especially if treatment is long term.

Oral solution handling and expiry checks

The oral solution needs the same careful attention, with no freezing and no use past expiry.

Alternatives, switching, and how tamoxifen compares with other hormone treatments

Sometimes patients are surprised when their specialist mentions a switch from tamoxifen to another hormone treatment.

That usually reflects menopause status, side effects, or resistance rather than a mistake in care.

Tamoxifen is a SERM, while anastrozole, letrozole, and exemestane are aromatase inhibitors, so the medicines do not work in the same way.

Fulvestrant is an oestrogen receptor antagonist, and raloxifene is another SERM used for osteoporosis and breast cancer risk reduction.

Switch decisions may reflect tolerability, menopausal status, or resistance, including situations where treatment interruption is considered.

Before a switch, patients should ask about the reason, the new side-effect profile, and any monitoring needed.

How tamoxifen differs from aromatase inhibitors

Aromatase inhibitors reduce oestrogen production, while tamoxifen blocks the receptor in a tissue-selective way.

When fulvestrant or raloxifene may be discussed

These may be considered in different clinical pathways, depending on the treatment goal.

Why patients are switched between treatments

Menopause status, side effects, and response all influence the decision.

UK counselling points before a switch

Patients should confirm the new dose, timing, interaction risk, and follow-up plan before changing therapy.

Delivery across the United Kingdom